Close Menu

NEW YORK — The HudsonAlpha Institute for Biotechnology said on Monday that one of its postdoctoral researchers has won a $118,335 grant from the National Institutes of Health to continue research into the genetics of Alzheimer's disease.

With the funding, Nicholas Cochran — a senior postdoc in the lab of HudsonAlpha's Richard Myers — aims to study the regulation of the gene that encodes tau, a protein that is abnormally hyperphosphorylated and aggregates in the brains of Alzheimer's disease patients, and how it is influenced by rare variants.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.